Company news
Schrodinger, Inc. news in 2021
Schrodinger, Inc.'s news releases, calls and decks from 2021, newest first.
Schrödinger Announces Retirement of Chief Financial Officer Joel Lebowitz
December 20, 2021
Schrödinger Reports Preclinical Data Supporting Advancement Of Its MALT1 Inhibitor Program At American Society Of Hematology 2021 Annual Meeting
December 10, 2021
Schrödinger to Participate in Five Upcoming Investor Conferences
November 21, 2021
Schrödinger Awarded Grant to Accelerate Drug Discovery in Women’s Health
November 17, 2021
Schrödinger Reports Third Quarter 2021 Financial Results and Provides Company Update
November 9, 2021
Schrödinger to Present New Preclinical Data From Its MALT1 Inhibitor Program at ASH 2021 Annual Meeting
November 3, 2021
Schrödinger to Host Conference Call to Discuss Third Quarter 2021 Financial Results
October 28, 2021
Centessa Pharmaceuticals Subsidiary, Orexia Therapeutics, and Schrödinger Announce Collaboration to Discover Novel Orexin Receptor Agonists
October 17, 2021
MD Anderson and Schrödinger Announce Strategic Research Collaboration to Accelerate Development of WEE1 Program
October 6, 2021
Schrödinger to Present at Four Investor Conferences in September
September 2, 2021
Schrödinger Reports Second Quarter 2021 Financial Results and Provides Company Update
August 11, 2021
Schrödinger and Zai Lab Announce a Global R&D Collaboration in Oncology
August 3, 2021
Schrödinger to Host Conference Call to Discuss Second Quarter 2021 Financial Results
July 29, 2021
Schrödinger Hosts First Annual Educator’s Day and Announces “Teaching with Schrödinger” Program
July 27, 2021
Schrödinger to Present at Two Virtual Investor Conferences in July
July 13, 2021
Schrödinger to Present at Two Investor Healthcare Conferences in June
May 24, 2021
Schrödinger Reports First Quarter 2021 Financial Results and Provides Company Update
May 10, 2021
Schrödinger to Present at the Bank of America Securities 2021 Virtual Healthcare Conference
May 3, 2021
Schrödinger to Host Conference Call to Discuss First Quarter 2021 Financial Results
April 26, 2021
Schrödinger Reports Preclinical Data on Novel, Selective CDC7 Inhibitors Presented at American Association for Cancer Research Annual Meeting
April 11, 2021
Schrödinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery
April 8, 2021
Schrödinger to Host Webcast in Conjunction with Presentation of Preclinical Data for Its CDC7 Program at Virtual AACR Annual Meeting
March 29, 2021
Schrödinger to Participate in Credit Suisse 2021 Healthcare Innovators Series: The Intersection of Drug Discovery, Drug Development and Artificial Intelligence
March 16, 2021
Schrödinger Announces Preclinical Data for CDC7 Program to Be Presented at AACR Virtual Annual Meeting 2021
March 9, 2021
Schrödinger Reports Financial Results for the Fourth Quarter and Full Year 2020 and Provides Outlook for 2021
March 3, 2021
Schrödinger to Present at the H.C. Wainwright Global Life Sciences Conference
February 28, 2021
Schrödinger Expands Agreement with Google Cloud to Further Bolster Its Drug Discovery and Materials Science Initiatives
February 24, 2021
Schrödinger to Present at the SVB Leerink Partners 10th Annual Global Healthcare Conference
February 18, 2021
Schrödinger to Host Conference Call to Discuss Fourth Quarter and Year-End 2020 Financial Results
February 17, 2021
Calls in 2021
Decks in 2021
- Investor Presentation (March 2021)
Investor deck · 30 slides · Mar 23, 2021